Association of serum phosphate with vascular and valvular calcification in moderate CKD

Kathryn L Adeney1, David S Siscovick, Joachim H Ix

  • 1University of Washington, Department of Epidemiology, Harborview Medical Center, Seattle, WA 98104, USA.

Insights

Higher serum phosphate levels, even within the normal range, are linked to increased vascular and valvular calcification in individuals with chronic kidney disease (CKD). This suggests phosphate may play a direct role in calcification risk for CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Elevated serum phosphate is a known risk factor for cardiovascular events and mortality in chronic kidney disease (CKD) and normal kidney function populations.
  • Experimental data indicates phosphate directly promotes vascular smooth muscle calcification.

Purpose of the Study:

  • To investigate the association between serum phosphate concentrations and vascular and valvular calcification in individuals with moderate CKD.
  • To determine if normal-range phosphate levels impact calcification prevalence in CKD patients.

Main Methods:

  • Analysis of 439 participants from the Multi-Ethnic Study of Atherosclerosis with moderate CKD and no prior cardiovascular disease.
  • Measurement of coronary artery, thoracic aorta, aortic valve, and mitral valve calcification using computed tomography.
  • Statistical adjustment for demographics, estimated glomerular filtration rate (eGFR), traditional atherosclerosis risk factors, parathyroid hormone, and 1,25-dihydroxyvitamin D levels.

Main Results:

  • 95% of participants had serum phosphate concentrations within the normal range (2.5–4.5 mg/dl).
  • Increased serum phosphate was significantly associated with higher prevalence of coronary artery (21%), thoracic aorta (33%), and mitral valve (62%) calcification.
  • These associations persisted after adjusting for multiple confounding factors, including eGFR and traditional cardiovascular risk factors.

Conclusions:

  • Higher serum phosphate concentrations, even within the normal range, are associated with increased vascular and valvular calcification in moderate CKD.
  • Phosphate may be an independent risk factor for calcification in CKD.
  • Further research is needed to determine if phosphate-lowering therapies can mitigate calcification risk in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily regulated...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...